Company intelligence / Profile preview

Liqmeds Lifecare

Weedon, Northamptonshire, United Kingdom

Ownership: Private
Development stage: Other

Overview

Liqmeds Lifecare, now part of the Zydus group, specializes in oral liquid formulations for oncology and non-oncology indications. It recently launched and commercialized IMKELDI (imatinib oral solution), the first oral liquid imatinib approved for leukemia and certain cancers[2]. The company's model centers on both internal development and partnerships for global distribution, with manufacturing in the UK and products marketed in the US, UK, Europe, and Canada[3][7][9].

Therapeutic areas: OncologyHematology
Modalities: Small molecule
Industry: Biotech

Partnerships

Shilpa Medicare (Oncosol JV for IMKELDI)[2]Koana Healthcare Limited (JV partner)[2]Shorla Oncology (distribution partner for IMKELDI)[2]

Beyond the preview

Go deeper on Liqmeds Lifecare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liqmeds Lifecare.

Explore the full profile